Oliver Wiedow

Chief Executive Officer en PROTEO, INC. .

66 años

Health Technology

Consumer Services

Perfil

Oliver Wiedow is the founder of tiakis BIOTECH AG, a company founded in 2000, where he currently holds the title of Chairman-Supervisory Board.
He is also the founder of Proteo, Inc., a company founded in 2000, where he currently holds the titles of President, Chief Executive Officer, CFO & Director.
Additionally, Dr. Wiedow is the founder of the University of Kiel, where he holds the title of Professor-Dermatology since 1985.

Cargos activos de Oliver Wiedow

Empresas	Cargo	Inicio
PROTEO, INC.	Chief Executive Officer	15/11/2018
tiakis BIOTECH AG tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow.	Founder	23/05/2012
University of Kiel	Corporate Officer/Principal	01/01/1999

Todos los cargos activos de Oliver Wiedow

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Oliver Wiedow.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Proteo, Inc. Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA.	Health Technology
tiakis BIOTECH AG tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow.	Health Technology